Hyperphosphatemia is a common complication in the later stages of chronic kidney disease (CKD). Sequelae can include hypocalcemia, disturbances in bone mineralization homeostasis, and an increased…
Chronic kidney disease (CKD) is a general term for a set of heterogeneous disorders that negatively affect the function and structure of the kidney. Because of the role of the kidney in many of the…
The Current Treatment Bone and Mineral Metabolism (BMM) disorders content examines the management of dialysis and mid- to late-stage chronic kidney disease (CKD) patients from the perspective of…
The CurrentTreatment Bone and Mineral Metabolism (BMM) disorders content examines the management of dialysis and mid- to late-stage chronic kidney disease (CKD) patients from the perspective of…
A syndicated report that will provide information on various hyperphosphatemia market dynamics. It provides insight into practice patterns, attitudes and perceptions, and current and projected…
Payer and Physician Receptivity to Novel Treatments—Which Emerging Drugs Excite Them? Hyperphosphatemia, or treatment of elevated serum phosphorous levels, typically found as a complication of…
Payer and Physician Receptivity to Novel Treatments—Which Emerging Drugs Excite Them? Hyperphosphatemia, or treatment of elevated serum phosphorous levels, typically found as a complication of…